{"Name":"Calixa Therapeutics","perma":"calixa-therapeutics","BasicInfo":{"funded":"2007-01-01","isClosed":false,"closed":null,"short":"Calixa Therapeutics, a biopharmaceutical company, develops a novel cephalosporin to address the problem of multi-drug resistant organisms."},"FundingRounds":[],"Acquisitions":[],"AcquiredBy":{"price":92500000,"paymentType":"cash","announcedDate":"2009-12-14","completedDate":null,"acquisitionType":null,"acquirer":"Cubist Pharmaceuticals"},"IPO":null,"Investments":[],"Products":[],"ProductsPermas":[],"CurrentTeam":[{"title":"Chief Medical Officer","started":null,"ended":null,"firstName":"Ian","lastName":"Friedland"},{"title":"Executive Vice President and CSO","started":null,"ended":null,"firstName":"James","lastName":"(Yigong) Ge"}],"PastTeam":[{"title":"Founder & CEO","started":null,"ended":null,"firstName":"Dennis","lastName":"Podlesak"},{"title":"Led a Number ofSuccessful Investments","started":null,"ended":null,"firstName":"Brett","lastName":"Ahrens"}]}
